HLA-A and neoplasm: pMHC-I multimers were assembled for each of the 107 selected neoepitopes accompanied by screening for 24 epitopes derived from tumor-associated antigens and 17 epitopes from viral peptides predicted to be presented by any of the patient’s six HLA-A,B,C allotypes (Figure 7A).